These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

658 related items for PubMed ID: 29045037

  • 1. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
    Colliard S, Jourde-Chiche N, Clavarino G, Sarrot-Reynauld F, Gout E, Deroux A, Fougere M, Bardin N, Bouillet L, Cesbron JY, Thielens NM, Dumestre-Pérard C.
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1263-1268. PubMed ID: 29045037
    [Abstract] [Full Text] [Related]

  • 2. Association between the Presence of Autoantibodies Targeting Ficolin-3 and Active Nephritis in Patients with Systemic Lupus Erythematosus.
    Plawecki M, Lheritier E, Clavarino G, Jourde-Chiche N, Ouili S, Paul S, Gout E, Sarrot-Reynauld F, Bardin N, Boëlle PY, Chiche L, Bouillet L, Thielens NM, Cesbron JY, Dumestre-Pérard C.
    PLoS One; 2016 Aug; 11(9):e0160879. PubMed ID: 27631981
    [Abstract] [Full Text] [Related]

  • 3. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H, Ekblom-Kullberg S, Miettinen A.
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [Abstract] [Full Text] [Related]

  • 6. Two-Parametric Immunological Score Development for Assessing Renal Involvement and Disease Activity in Systemic Lupus Erythematosus.
    Sjöwall C, Bentow C, Aure MA, Mahler M.
    J Immunol Res; 2018 Jun; 2018():1294680. PubMed ID: 30246032
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A study on anti-mannose binding lectin (anti-MBL) antibodies and serum MBL levels in Indian systemic lupus erythematosus patients.
    Pradhan V, Mahant G, Rajadhyaksha A, Surve P, Rajendran V, Patwardhan M, Nadkarni A, Dighe S, Ghosh K.
    Rheumatol Int; 2013 May; 33(5):1193-9. PubMed ID: 22971892
    [Abstract] [Full Text] [Related]

  • 9. Significance of Anti-C1q Antibodies in Patients with Systemic Lupus Erythematosus as A Marker of Disease Activity and Lupus Nephritis.
    Soliman AF, Egailla SE, Abdel-Gawad ER, Mansour AI, ElKhouly TH, Mahgoub MY.
    Egypt J Immunol; 2016 Jan; 23(1):107-116. PubMed ID: 28502158
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus.
    Haddon DJ, Diep VK, Price JV, Limb C, Utz PJ, Balboni I.
    Arthritis Res Ther; 2015 Jun 17; 17(1):162. PubMed ID: 26081107
    [Abstract] [Full Text] [Related]

  • 12. Anti-Ficolin-2 and Anti-Ficolin-3 Autoantibody Detection by ELISA.
    Dumestre-Pérard C, Thielens NM.
    Methods Mol Biol; 2021 Jun 17; 2227():121-132. PubMed ID: 33847937
    [Abstract] [Full Text] [Related]

  • 13. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 17; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 14. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.
    Picard C, Lega JC, Ranchin B, Cochat P, Cabrera N, Fabien N, Belot A.
    Pediatr Nephrol; 2017 Sep 17; 32(9):1537-1545. PubMed ID: 28343355
    [Abstract] [Full Text] [Related]

  • 15. Cut-off values of immunological tests to identify patients at high risk of severe lupus nephritis.
    Gargiulo MLÁ, Khoury M, Gómez G, Grimaudo S, Suárez L, Collado MV, Sarano J.
    Medicina (B Aires); 2018 Sep 17; 78(5):329-335. PubMed ID: 30285925
    [Abstract] [Full Text] [Related]

  • 16. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z, El Anbari M, Anwar S, Mortimer A, Marr N, Karim MY.
    Lupus; 2019 May 17; 28(6):713-721. PubMed ID: 31046570
    [Abstract] [Full Text] [Related]

  • 17. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients.
    Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, Baba S, Hara M, Yamanaka H.
    Arthritis Rheum; 2011 Aug 17; 63(8):2436-44. PubMed ID: 21506094
    [Abstract] [Full Text] [Related]

  • 18. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
    Zivković V, Stanković A, Cvetković T, Mitić B, Kostić S, Nedović J, Stamenković B.
    Srp Arh Celok Lek; 2014 Aug 17; 142(7-8):431-6. PubMed ID: 25233687
    [Abstract] [Full Text] [Related]

  • 19. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X, Ren L, Sun G, Yu T, Yao Y, Wang L, Liu F, Zhang L, He X, Liu M.
    Immun Inflamm Dis; 2021 Jun 17; 9(2):407-418. PubMed ID: 33470559
    [Abstract] [Full Text] [Related]

  • 20. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients.
    Syahidatulamali CS, Wan Syamimee WG, Azwany YN, Wong KK, Che Maraina CH.
    J Postgrad Med; 2017 Jun 17; 63(4):257-261. PubMed ID: 28862243
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.